# clm_7DA2AEFA0080

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: total_equity  
value: 930,498,000 United States dollar  
valid_from: 2012-03-31  
valid_to: 2012-06-30  
published: 2012-05-10  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_72E671723425  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals total equity: 930,498,000 United States dollar", as of 2012-03-31 (until 2012-06-30). Claim clm_7DA2AEFA0080, https://asof.is/claim/clm_7DA2AEFA0080, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000104746912005755/0001047469-12-005755-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q1 FY2012, filed 2012-05-10  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000104746912005755/0001047469-12-005755-index.htm (primary, SEC EDGAR 10-Q Q1 FY2012, published 2012-05-10)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | total_equity | 786,843,000 United States dollar | valid 2011-12-31 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_7DA2AEFA0080](/claim/clm_7DA2AEFA0080.md) | [clm_46A87149904E](/claim/clm_46A87149904E.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.
